Complete remission of stage IV erythrodermic mycosis fungoides with large cell transformation through combination of pralatrexate and romidepsin followed by allogeneic hematopoietic stem cell transplantation

Aaron J. Frederiks, Katherine J. Creeper, Dominic V. Spagnolo, Paul Cannell, Dejan Radeski

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

We report the case of a 59-year-old woman with stage IV erythrodermic mycosis fungoides (MF) and large cell transformation who, despite failing multiple previous treatments, achieved complete remission through a combination of pralatrexate and romidepsin followed by allogeneic hematopoietic stem cell transplantation (alloSCT). Further studies are needed in focussing on this combined regimen in treating cutaneous T-cell lymphoma (CTCL) and its efficacy as a bridging regimen in facilitating successful alloSCT.

Original languageEnglish
Pages (from-to)e400-e403
JournalAustralasian Journal of Dermatology
Volume62
Issue number3
Early online date2021
DOIs
Publication statusPublished - Aug 2021

Fingerprint

Dive into the research topics of 'Complete remission of stage IV erythrodermic mycosis fungoides with large cell transformation through combination of pralatrexate and romidepsin followed by allogeneic hematopoietic stem cell transplantation'. Together they form a unique fingerprint.

Cite this